白细胞介素-15 超激动剂（N-803）治疗异基因造血干细胞移植后患者的 PML 和 JCV。
Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.
机构信息
Division of Oncology and.
Department of Neurology, Washington University in St. Louis, St. Louis, MO.
出版信息
Blood Adv. 2020 Jun 9;4(11):2387-2391. doi: 10.1182/bloodadvances.2019000664.
Abstract
Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.
摘要
IL-15 超级激动剂治疗导致 PML 移植受者出现免疫和临床应答。
相似文献
1
Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.
Blood Adv. 2020 Jun 9;4(11):2387-2391. doi: 10.1182/bloodadvances.2019000664.
2
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
Bone Marrow Transplant. 2011 Jul;46(7):987-92. doi: 10.1038/bmt.2010.221. Epub 2010 Oct 4.
3
Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation-can preemptive detection of John Cunningham virus be useful?
Int J Infect Dis. 2014 Sep;26:107-9. doi: 10.1016/j.ijid.2014.03.1381. Epub 2014 Jul 16.
4
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes.
J Transl Med. 2020 Apr 21;18(1):177. doi: 10.1186/s12967-020-02337-5.
5
Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantation.
Antivir Ther. 2017;22(8):721-725. doi: 10.3851/IMP3162.
6
Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).
Eur J Haematol. 2014 Jan;92(1):83-7. doi: 10.1111/ejh.12208. Epub 2013 Oct 25.
7
Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.
Bone Marrow Transplant. 2007 Jan;39(2):101-7. doi: 10.1038/sj.bmt.1705548. Epub 2006 Dec 4.
8
Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
JAMA Neurol. 2018 Jul 1;75(7):827-833. doi: 10.1001/jamaneurol.2018.0094.
9
Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient.
Am J Transplant. 2005 May;5(5):1151-8. doi: 10.1111/j.1600-6143.2005.00800.x.
10
Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy.
J Neurol Sci. 2016 Sep 15;368:304-6. doi: 10.1016/j.jns.2016.07.045. Epub 2016 Jul 22.
引用本文的文献
1
Therapeutic advances in neuroinfectious diseases.
Ther Adv Infect Dis. 2024 Sep 20;11:20499361241274246. doi: 10.1177/20499361241274246. eCollection 2024 Jan-Dec.
2
Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report.
Ther Adv Hematol. 2023 Oct 9;14:20406207231201721. doi: 10.1177/20406207231201721. eCollection 2023.
3
Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells.
J Infect Dis. 2024 Jun 14;229(6):1836-1844. doi: 10.1093/infdis/jiad424.
4
Advances in Treatment of Progressive Multifocal Leukoencephalopathy.
Ann Neurol. 2021 Dec;90(6):865-873. doi: 10.1002/ana.26198. Epub 2021 Sep 7.
本文引用的文献
1
Sustained Response and Rationale of Programmed Cell Death-1-Targeting for Progressive Multifocal Leukoencephalopathy.
Open Forum Infect Dis. 2019 Sep 30;6(10):ofz374. doi: 10.1093/ofid/ofz374. eCollection 2019 Oct.
2
IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapy.
AIDS. 2019 Oct 1;33(12):1954-1956. doi: 10.1097/QAD.0000000000002278.
3
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
N Engl J Med. 2019 Apr 25;380(17):1676-1677. doi: 10.1056/NEJMc1817193. Epub 2019 Apr 10.
4
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10.
5
Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
N Engl J Med. 2019 Apr 25;380(17):1674-1676. doi: 10.1056/NEJMc1816198. Epub 2019 Apr 10.
6
Progressive multifocal leukoencephalopathy treated with nivolumab.
J Neurovirol. 2019 Apr;25(2):284-287. doi: 10.1007/s13365-019-00738-x. Epub 2019 Mar 12.
7
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
N Engl J Med. 2018 Oct 11;379(15):1443-1451. doi: 10.1056/NEJMoa1801540.
8
Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia.
J Neurovirol. 2018 Oct;24(5):652-655. doi: 10.1007/s13365-018-0657-x. Epub 2018 Jul 9.
9
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Lancet Oncol. 2018 May;19(5):694-704. doi: 10.1016/S1470-2045(18)30148-7. Epub 2018 Apr 5.
10
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Blood. 2018 Jun 7;131(23):2515-2527. doi: 10.1182/blood-2017-12-823757. Epub 2018 Feb 20.
Zotero 插件